Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Colonoscopy

Colonoscopy

BACK

Colonoscopy

The diagnosis and severity grading of intestinal conditions such as Crohn’s disease typically require a complete colonoscopy with biopsy and relative histopathology exam. The VIGOR++ system makes possible to replace these invasive, unpleasant, and expensive exams with a simple magnetic resonance imaging session, followed by a patient-specific computer simulation.

The VIGOR++ software is now available for clinical research use via the 3Dnet™ medical imaging cloud service (www.3dnetmedical.com). Full-scale clinical trials are being designed at the Academic Medical Center, Amsterdam, and the UCL Hospital, London.

Tielbeek JA, Löwenberg M, Bipat S, Horsthuis K, Ponsioen CY, D'Haens GR, Stoker J. Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn's disease. Inflamm Bowel Dis. 2013 Aug;19(9):1943-50. 10.1097/MIB.0b013e3182905536
Tielbeek, JA; Makanyanga, JC; Bipat, S; Pendsé, DA; Nio, CY; Vos, FM; Taylor, SA; Stoker, J; - (2013) Grading Crohn Disease Activity With MRI: Interobserver Variability of MRI Features, MRI Scoring of Severity, and Correlation With Crohn Disease Endoscopic Index of Severity. AJR Am J Roentgenol, 201 (6) 1220 - 1228. DOI:10.2214/AJR.12.10341
Mahapatra D, Schueffler P, Tielbeek J, Makanyanga J, Stoker J, Taylor S, VosF, Buhmann J., Automatic Detection and Segmentation of Crohn's Disease Tissues from Abdominal MRI, IEEE Trans Med Imaging. 2013.
Public dissemination: Euronews documentary http://www.euronews.com/2013/07/01/crohn-s-disease-the-inside-story

IMAGE GALLERY:

NEWS

News Avicenna at FDA / MDIC Event in Washington, April 16 - 17

Avicenna at FDA / MDIC Event in Washington, April 16 - 17

Many representatives of the Avicenna Alliance networked with good friends and in silico thought leaders from around the world at the FDA / MDIC symposium on Computation Modeling & Simulation in Washington.

News The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

On April 10, the European Parliament overwhelmingly backed the reform of General Pharmaceutical Legislation (GPL), marking a pivotal moment in healthcare regulation. With a resounding majority, both the Directive and Regulation were embraced, reflecting a collaborative effort within the ENVI committee.

News The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

Tox by Design is a prominent European toxicological expertise firm specializing in conducting toxicological Risk Assessments (RAs) for various industries such as biotech, pharmaceuticals, cosmetics, medical devices, and API synthesis.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry